Common Contracts
43 similar Research and License Agreement contracts by Kosan Biosciences Inc, Biotransplant Inc, Centocor Diagnostics Inc, others
Exhibit 10.1 RESEARCH AND LICENSE AGREEMENT This License Agreement is entered into as of this 30th day of March, 2006 (the "Restated Effective Date"), by and between Brainstorm Cell Therapeutics Inc.(formerly Golden Hand Resources, Inc.), a company...Research and License Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
BETWEENResearch and License Agreement • March 20th, 2006 • Combinatorx, Inc • Pharmaceutical preparations • New York
EXHIBIT 10.46 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS([**]), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED...Research and License Agreement • October 5th, 2005 • Combinatorx, Inc • Pharmaceutical preparations • New York
EXHIBIT 10.1 RESEARCH AND LICENCE AGREEMENT ------------------------------Research and License Agreement • October 14th, 2003 • Bert Logic Inc • Telegraph & other message communications
EXHIBIT NO. 10.8 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. RESEARCH AND LICENSE AGREEMENT This Agreement is effective June 1, 1993 ("the EFFECTIVE DATE") by and between...Research and License Agreement • August 20th, 2003 • Nitromed Inc • Massachusetts
RECITALSResearch and License Agreement • November 20th, 2002 • Neogenomics Inc • Services-commercial physical & biological research • California
AMENDMENTResearch and License Agreement • July 30th, 2002 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.27 RESEARCH and LICENCE AGREEMENT (1) BIOENVISION INC.Research and License Agreement • June 24th, 2002 • Bioenvision Inc • Pharmaceutical preparations
RESEARCH AND LICENSE AGREEMENT This Agreement, dated as of 02 August 2001 (the "Effective Date"), is by and between Research and Diagnostic Systems, Inc., a Minnesota corporation with principal offices at 614 McKinley Place NE, Minneapolis, Minnesota...Research and License Agreement • September 27th, 2001 • Techne Corp /Mn/ • Biological products, (no disgnostic substances) • Minnesota
WITNESSETH:Research and License Agreement • June 5th, 2001 • Cambridge Antibody Technology Group PLC • Services-commercial physical & biological research • Illinois
Exhibit No. 10.6 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. EXTENSION OF RESEARCH AND LICENSE AGREEMENT BETWEEN THE GENERAL HOSPITAL CORPORATION AND BIOTRANSPLANT...Research and License Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations
Exhibit 10.8 RESEARCH AND LICENSE AGREEMENT This Agreement is effective April 5, 1994 ("the EFFECTIVE DATE") by and between Stem Cell Sciences Pty Ltd (ACN 063 293 130), 420 St. Kilda Road, Melbourne, 3004, Victoria, Australia ("SCS"), and...Research and License Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Victoria
SK 797) TABLE OF CONTENTS PREAMBLE ARTICLES:Research and License Agreement • December 28th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • New York
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • October 4th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • California
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • September 28th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • California
BETWEENResearch and License Agreement • September 7th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • New York
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • August 8th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • California
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • March 31st, 2000 • Kosan Biosciences Inc • California
BETWEENResearch and License Agreement • March 9th, 2000 • Tanox Inc • Services-medical laboratories
ANDResearch and License Agreement • August 3rd, 1999 • Lexon Inc/Ok
ASTRA AB ANDResearch and License Agreement • March 24th, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALSResearch and License Agreement • March 17th, 1999 • Axonyx Inc
1 Exhibit 10.1 AMENDMENT NO. 1 TO RESEARCH AND LICENSE AGREEMENT This Amendment No. 1, dated as of September 30, 1998 is between ArQule, Inc. ("ArQule") a Delaware Corporation and Roche Bioscience, a division of Syntex (U.S.A.) Inc. ("Roche...Research and License Agreement • November 16th, 1998 • Arqule Inc • Pharmaceutical preparations
RECITALSResearch and License Agreement • May 19th, 1998 • Hypertension Diagnostics Inc /Mn
Exhibit 10.66 Amendment of December 1997 to the Research and License Agreement between ImClone Systems Incorporated and Merck KGaA WHEREAS ImClone Systems (hereinafter "ImClone") and Merck KGaA (hereinafter "Merck" ) are parties to a Research and...Research and License Agreement • March 31st, 1998 • Imclone Systems Inc/De • Biological products, (no disgnostic substances)
Exhibit 10.65 Amendment of May 1996 to the Research and License Agreement between ImClone Systems Incorporated and Merck KGaA WHEREAS ImClone Systems (hereinafter "ImClone") and Merck KGaA (hereinafter "Merck") are parties to a Research and License...Research and License Agreement • March 31st, 1998 • Imclone Systems Inc/De • Biological products, (no disgnostic substances)
AMENDED AND RESTATED RESEARCH AND LICENSE AGREEMENT BETWEEN XOMA CORPORATION AND NEW YORK UNIVERSITY NYU/XOMA AMENDED AND RESTATED RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations
RESEARCH AND LICENSE AGREEMENT between BIOCHEM PHARMA, INC. and SCRIPTGEN PHARMACEUTICALS, INC. December 12, 1997Research and License Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
RESEARCH AND LICENSE AGREEMENT between BIOCHEM PHARMA, INC. and SCRIPTGEN PHARMACEUTICALS, INC. December 12, 1997Research and License Agreement • January 8th, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
CENTOCOR 244 GREAT VALLEY PARKWAY, MALVERN, PA 19355 (215) 296-4488 TELEX: 173-190 FAX: (215) 644-7558Research and License Agreement • December 11th, 1997 • Centocor Diagnostics Inc • In vitro & in vivo diagnostic substances • Arkansas
TABLE OF CONTENTSResearch and License Agreement • October 17th, 1997 • Vysis Inc • New York
CENTOCOR 244 GREAT VALLEY PARKWAY, MALVERN, PA 19355 (215) 296-4488 TELEX: 173-190 FAX: (215) 644-7558Research and License Agreement • October 16th, 1997 • Centocor Diagnostics Inc • Arkansas
EXHIBIT 10.23 AMENDED RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • October 9th, 1997 • Cell Pathways Inc • Arizona
ANDResearch and License Agreement • September 11th, 1997 • Megabios Corp • Services-commercial physical & biological research • Delaware
NYU/SUGENResearch and License Agreement • August 14th, 1997 • Sugen Inc • Biological products, (no disgnostic substances)
